President Trump is ending a Medicare drug subsidy that helped hold down premiums for millions of seniors.
Quick Take
- The Centers for Medicare and Medicaid Services says the subsidy will end after the 2026 plan year.
- Officials say the market has stabilized and the program is no longer needed.
- Reporters say many Medicare Part D enrollees could see higher costs in 2027.
- The administration says some people will still see small increases, flat rates, or lower premiums.
What the Trump Administration Announced
The Centers for Medicare and Medicaid Services said it will end the Part D Premium Stabilization Demonstration at the end of the 2026 plan year. Officials say that means the program will not continue into 2027 and that Part D plans will return to normal market rules. The administration’s message is simple: the subsidy was temporary, and it is now time to stop using federal dollars to cushion premiums.
That decision matters because the program was created to blunt premium spikes for stand-alone Medicare Part D drug plans. Reuters reported that the program was expected to provide insurers with about $3.6 billion in subsidies this year to cushion premium increases. The Wall Street Journal reported that officials said the subsidy had helped keep premiums manageable, while the administration now argues that insurers no longer need the extra support.
How Seniors Could Be Affected
The biggest question is not whether the subsidy ends. It is how much that change will show up in monthly bills. ABC reported that an administration official said the move will likely raise prescription costs and increase premiums for about half of recipients. ABC also reported that the administration expects most premium changes to stay under $10 a month, while KFF estimated some increases could reach as much as $20 a month.
Those numbers still leave plenty of uncertainty for seniors who live on fixed incomes. ABC and the New York Times both reported that enrollees will not learn their 2027 monthly costs until later this fall. That delay means the public is being asked to trust projections before final plan prices are known. For older Americans, that kind of uncertainty is exactly what drives frustration with Washington’s health-care maze.
Why the Administration Says the Cut Makes Sense
Administration officials say the subsidy distorted the market and encouraged higher bids from insurers. Reuters reported that an official told the Wall Street Journal the extra subsidies gave insurers an incentive to raise premiums because the government would absorb much of the added cost. The same report said the administration believes other steps aimed at controlling Part D costs are still in place, which is part of its case for ending the program now.
That argument fits a broader conservative view that temporary federal fixes often become permanent crutches. The administration is saying the same thing here: a subsidy built to stabilize a changing benefit should not last forever. CMS also said the program’s sunset will let Part D return to “traditional market conditions,” language that suggests the agency sees the market as able to stand on its own again.
AP: Trump's CMS is ending a Biden-era Medicare Part D subsidy, saying it stops billions from flowing to insurers. Democrats call it higher costs for seniors. Fiscal discipline or midterm risk? https://t.co/yeE6nhuUEN
— Alexander Rhodes (@TheDailyRightTK) July 31, 2026
Still, the facts also show why the move will be watched closely. Medicare Part D serves tens of millions of older and disabled Americans, and even a modest premium rise can hit hard when it lands on a fixed monthly budget. The 2026 Medicare drug benefit already includes a $2,100 out-of-pocket cap, but premiums are a separate cost that can still move up or down.
What to Watch Next
The final answer will come when 2027 plan filings become public later this fall. Until then, the administration’s case rests on projections, not final premiums. The likely result is uneven: some beneficiaries may see little change, some may see lower premiums, and others may face higher monthly costs. The real political fight now is over whether ending a temporary subsidy is a cleanup step or a cost shift to seniors.
Sources:
washingtontimes.com, abcnews.com, reuters.com, wsj.com, fiercehealthcare.com, usatoday.com, medicare.gov














